Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000008

Chief Medical Officer sold 7,100 shares at $50.16 ($356,112)

  • Chief Medical Officer acquired 7,100 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-13 Exercise or conversion : show line 1 in the form +7,100 $35.16 $249,636 8,750 D
2020-02-13 Sale : show line 2 in the form −7,100 $50.16 $356,112 1,650 D
Open-market sales · 7,100 sh · avg $50.16 · $356,112

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-13 Exercise or conversion : show line 3 in the form Stock option (right to buy) −7,100 19,306 D
Loading xslF345X03/wf-form4_158205991627413.xml…